News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Novartis AG (NVS), GlaxoSmithKline (GSK) Reshape Pharma With Game-Changing $14.5 Billion Deal


4/22/2014 6:56:11 AM

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

Two of the world's largest pharmaceutical companies have joined forces to create a joint venture, with GlaxoSmithKline (GSK) and Swiss firm Novartis agreeing to create a new consumer healthcare business. Novartis said on Tuesday it had agreed to acquire GSK's oncology products for $14.5 billion, plus an additional $1.5 billion contingent on a development milestone. GSK, meanwhile, will pay $7.1 billion plus royalties for Novartis' vaccines business, excluding its flu business, Novartis said. The GSK and Novartis joint consumer healthcare venture will generate approximately £6.5 billion ($10.9 billion) in annual sales, according to GSK.

Help employers find you! Check out all the jobs and post your resume.

Read more at Reuters.

Read at CNBC
Read at Reuters
Read at Belfast Telegraph
Read at Wall Street Journal


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES